Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer
- 1 January 2002
- journal article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 19 (6) , 527-534
- https://doi.org/10.1023/a:1020392309715
Abstract
Considering recent findings that cyclooxygensase-2 (COX-2) is involved in the progression of colorectal carcinoma (CRC), the role of COX-2 in promoting invasion and angiogenesis was investigated by...Keywords
This publication has 50 references indexed in Scilit:
- Non‐steroidal anti‐inflammatory drugs inhibit matrix metalloproteinase‐2 expression via repression of transcription in lung cancer cellsFEBS Letters, 2001
- Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44Journal of Biological Chemistry, 2001
- Expression of soluble urokinase plasminogen activator receptor may be related to outcome in prostate cancer patients.Oncology Reports, 2000
- A Selective Cyclooxygenase‐2 Inhibitor Suppresses Tumor Growth in Nude Mouse Xenografted with Human Head and Neck Squamous Carcinoma CellsJapanese Journal of Cancer Research, 1999
- Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.1997
- Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?The Journal of cell biology, 1996
- Expression of cyclooxygenase-1 and -2 in human colorectal cancer.1995
- Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using anin vitro Matrigel modelJournal of Neuro-Oncology, 1994
- Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activatorExperimental Cell Research, 1992
- UROKINASE-PLASMINOGEN ACTIVATOR, A NEW AND INDEPENDENT PROGNOSTIC MARKER IN BREAST-CANCER1990